Umecrine Cognition AB
556698-3655ActiveDeveloping novel drugs for neurological disorders caused by neuroinflammation.
Biotechnology Companyumecrinecognition.com
Yleiskatsaus
- 1–4
- Työntekijät
- ≤1t SEK
- Liikevaihto
- 2006
- Perustettu
Avainpäättäjät
Viktor Drvota
CEO and Chairman of the Board
@umecrine.se+46852XXXXXX
Magnus Doverskog
SVP & Chief Scientific Officer
@umecrine.se
Pernilla Sandwall
Chief Operating Officer
@umecrine.se
Thomas P. Blackburn
Non-executive Director
+6 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Umecrine Cognition AB is a biotechnology company focused on developing novel treatments for neurological disorders in the brain. Their primary scientific focus is on GABAA receptor modulating steroid antagonists. They aim to treat cognitive disorders caused by neuroinflammation resulting from a wide...